Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

Showing 77 results

Search by release date:: Jan, 2019 ～ Dec, 2019

December 11, 2019
Otsuka Holdings Otsuka Pharmaceutical

Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd.
December 11, 2019
Otsuka Pharmaceutical

Announcement of Changes in Company Officers at Otsuka Pharmaceutical Co., Ltd.
December 9, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical's Development of a Therapeutic Drug for Duchenne Muscular Dystrophy (TAS-205) Selected for AMED's CiCLE Program
December 9, 2019
Otsuka Pharmaceutical

Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution
December 6, 2019
Taiho Pharmaceutical

MSD and Taiho Pharmaceutical terminate co-promotion contract for anti-PD-1 antibody/anti-cancer drug KEYTRUDA® In Japan
November 28, 2019
Otsuka Pharmaceutical

POConePlus® Infrared Spectrophotometer for Diagnosis of H. pylori infection launched in Japan
November 27, 2019
Otsuka Pharmaceutical

Construction Completed on Otsuka's New Pharmaceutical Factory Plant in Mima City, Tokushima Prefecture, Japan
November 27, 2019
Otsuka Pharmaceutical

Otsuka Launches New SAMSCA Formulation in Japan: SAMSCA® OD Tablets
November 18, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Cosponsors "Asan Walking Festa in Itano" as Part of Community Health Promotion Efforts
November 12, 2019
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Pharmaceutical and Avanir Pharmaceuticals to Continue Clinical Development of Investigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer’s Dementia
November 12, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical and Avanir Pharmaceuticals to Continue Clinical Development of Investigational AVP-786 for the Treatment of Agitation in Patients with Alzheimer's Dementia
October 28, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Greenhouse Gas Emissions Reduction Targets Earn Science Based Targets (SBT) Initiative Certification
October 16, 2019
Otsuka Pharmaceutical

RS Virus Rapid-measurement Kit Quick NaviTM-RSV2 To Be Launched in Japan - Faster test results and enhanced visual features with two color lines -
October 15, 2019
Otsuka Pharmaceutical

Presentation of Effects of lactic acid bacterium B240 at Palynological Society of Japan
October 1, 2019
Otsuka Pharmaceutical

Three New Flavors of Easy-to-Drink Balanced Nutrition Beverage Introducing Calorie Mate Liquid
September 27, 2019
Otsuka Holdings Otsuka Pharmaceutical

Otsuka's Subsidiary Avanir Pharmaceuticals Reports Top-line Data from Second Phase 3 Trial Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia
September 27, 2019
Otsuka Pharmaceutical

Otsuka's Subsidiary Avanir Pharmaceuticals Reports Top-line Data from Second Phase 3 Trial Evaluating Investigational AVP-786 for the Treatment of Moderate-to-Severe Agitation in Patients with Alzheimer's Dementia
September 26, 2019
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Applies for the Additional Indication in Japan of Bipolar Disorder for ABILIFY MAINTENA for Suspended Release Injectable Suspension
September 26, 2019
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory develops Cellstor®-S cell suspension and preservation solution and Cellstor®-W cell wash and preservation solution - Research reagents leading to applications in regenerative medicine products -
September 26, 2019
Otsuka Pharmaceutical

Otsuka Applies for the Additional Indication in Japan of Bipolar Disorder for ABILIFY MAINTENA for Suspended Release Injectable Suspension
September 26, 2019
Otsuka Pharmaceutical

New Series Expands the SOYJOY Line of Whole Soy Nutrition Bars SOYJOY Scone Bar Plain
September 24, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical to Support the Pink Ribbon Campaign Again in 2019
September 20, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Obtains Approval of Additional Dosage and Administration for Breast Cancer in Japan for Antitumor Agent ABRAXANE® I.V. Infusion 100 mg
September 20, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Greenhouse Gas Emissions Reduction Targets Earn Science Based Targets (SBT) Initiative Certification
September 13, 2019
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches a concentrated liquid diet product “Hine E-Gel® LC,” a new line of “Hine E-Gel®” which changes from a liquid to a gel in the stomach
September 13, 2019
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Cooperative Agreement with Niigata Prefecture to Support Prefectural Residents' Health Promotion Project
September 6, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Obtains Approval of Anticancer Agent TAS-102 (brand name in Japan "Lonsurf®") in China for Treatment of Colorectal Cancer
September 6, 2019
Taiho Pharmaceutical

LONSURF® (trifluridine/tipiracil) Receives Marketing Authorization in Europe for Previously Treated Metastatic Gastric Cancer
August 29, 2019
Taiho Pharmaceutical

Taiho Pharmaceutical Releases Second Product under the Pitas Brand Pitas Cough Troche for Coughs and Phlegm, a Sticker-type Troche Helpful in Business Meetings
August 28, 2019
Otsuka Pharmaceutical

Approval for the Additional Formulation of Samsca® OD Tablets in Japan